Prescription drug costs

President Donald Trump speaks during an event to sign executive orders on lowering drug prices, in the South Court Auditorium in the White House complex, Friday, July 24, 2020, in Washington. (AP Photo/Alex Brandon)
July 24, 2020 - 9:18 pm
WASHINGTON (AP) — Unable to land the big deal with Congress to curb drug costs, President Donald Trump has moved on his own to allow imports of cheaper medicines, along with other limited steps that could have some election-year appeal. At a White House ceremony Friday, Trump signed four executive...
Read More
President Donald Trump speaks during an event to sign executive orders on lowering drug prices, in the South Court Auditorium in the White House complex, Friday, July 24, 2020, in Washington. (AP Photo/Alex Brandon)
July 24, 2020 - 6:23 pm
WASHINGTON (AP) — Unable to land the big deal with Congress to curb drug costs, President Donald Trump on Friday moved on his own to allow imports of cheaper medicines, along with other limited steps that could have some election-year appeal. At a White House ceremony, Trump signed four executive...
Read More
House Speaker Nancy Pelosi of Calif., speaks at a news conference on Capitol Hill in Washington, Friday, June 26, 2020. (AP Photo/Carolyn Kaster)
June 29, 2020 - 9:08 am
WASHINGTON (AP) — Democrats pushed a strengthening of “Obamacare” patient protections toward House passage Monday, an effort they hoped would help them sharpen the coronavirus pandemic and President Donald Trump's efforts to scuttle the increasingly popular law into a lethal campaign-season weapon...
Read More
FILE - This is an April 30, 2020, file photo showing Gilead Sciences headquarters in Foster City, Calif. The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday, June 29 for remdesivir, and said the price would be $3,120 for patients with private insurance. It will sell for far less in poorer countries where generic drugmakers are being allowed to make it. (AP Photo/Ben Margot, File)
June 29, 2020 - 8:54 am
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries. Gilead Sciences announced the price Monday for...
Read More
FILE - In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. In a major legal setback for President Donald Trump on a high-profile consumer issue, a federal appeals court has ruled that his administration lacks the legal authority to force drug companies to disclose prices in their TV ads. (AP Photo/Elise Amendola, File)
June 17, 2020 - 10:01 am
WASHINGTON (AP) — In a major legal setback for President Donald Trump on a high-profile consumer issue, a federal appeals court has ruled that his administration lacks the legal authority to force drug companies to disclose prices in their TV ads. The ruling denies Trump an easy-to-understand win...
Read More
This microscope image made available by the National Cancer Institute Center for Cancer Research in 2015 shows human colon cancer cells with the nuclei stained red. On Friday, May 29, 2020, doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. (NCI Center for Cancer Research via AP)
May 29, 2020 - 5:32 am
Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. Gentler drugs would be a relief to patients like Jenn Carroll, a 57-year-old human resources director from New Hartford,...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas.At least 13 states have obtained a total of more than 10 million doses of malaria drugs to treat COVID-19 patients despite warnings from doctors that more tests are needed before the medications that President Trump once fiercely promoted should be used to help people with the coronavirus. (AP Photo/John Locher,File)
April 28, 2020 - 5:46 pm
OKLAHOMA CITY (AP) — Republican state leaders in Oklahoma and Utah are facing scrutiny for spending millions of dollars combined to purchase malaria drugs promoted by President Trump to treat COVID-19 patients that many other states obtained for free and that doctors warned shouldn't be used...
Read More
FILE- In this Aug. 4, 2017 file photo, former pharmaceutical company CEO, Martin Shkreli, arrives at federal court in New York. The convicted former drug company wants out of prison so he can help research a treatment for the coronavirus. Shkreli's attorney said Tuesday, April 7, 2020, that he will be filing court papers asking federal authorities to release Shkreli for three months so he can do laboratory work “under strict supervision.” (AP Photo/Seth Wenig, File)
April 07, 2020 - 2:56 pm
NEW YORK (AP) — Convicted former drug company CEO Martin Shkreli, known as “Pharma Bro,” wants to get out of prison so he can help research a treatment for the coronavirus, his lawyer said Tuesday. Defense attorney Ben Brafman said that he will file court papers asking federal authorities to...
Read More
FILE - In this June 19, 2015, file the Justice Department Building in Washington. The Justice Department says pharmaceutical company Sandoz Inc. will pay a $195 million penalty to resolve criminal charges of conspiring to fix prices and rig bids for generic drugs. Officials say Monday, March 2, 2020, that the company would admit guilt and pay the penalty. (AP Photo/Andrew Harnik, File)
March 02, 2020 - 4:00 pm
WASHINGTON (AP) — The Justice Department said Monday that pharmaceutical company Sandoz Inc. will pay a $195 million penalty to resolve criminal charges of conspiring to fix prices and rig bids to stifle competition for generic drugs. As part of the agreement, the generic pharmaceutical company...
Read More
This undated photo provided by Esperion Inc. shows the cholesterol-lowering drug Nexletol made by Esperion Therapeutics Inc. The Food and Drug Administration on Friday, Feb. 21, 2020 approved Esperion Therapeutics Inc.’s Nexletol for people genetically predisposed to have sky-high cholesterol and others who have heart disease and need to further lower their bad cholesterol.(Esperion Inc. via AP)
Associated Press
February 21, 2020 - 1:15 pm
TRENTON, N.J. (AP) — U.S. regulatorson Friday approveda new type of cholesterol-lowering drug aimed at millions of people who can't tolerate — or don't get enough help from — widely used statin pills like Lipitor and Crestor. The Food and Drug Administration approved Esperion Therapeutics Inc.’s...
Read More

Pages